Login | October 19, 2025

Community Health Center announces new CEO

Published: August 19, 2013

AKRON––The Community Health Center (CHC) board of directors announces the appointment of Robert Stokes as chief executive officer.

Stokes brings over 25 years of experience in healthcare management and treatment services to CHC, including hospital administrative and seven years of executive level responsibilities leading regional behavioral health and substance abuse treatment agencies.

“Bob brings great experience from different healthcare environments,” said said Incoming Board President Doug Mory. “We are excited to have been able to find such a strong, innovative professional to lead CHC.”

Most recently, Stokes served as president and CEO of Compass Corporation for Recovery Services in Toledo, a nonprofit organization providing detoxification, methadone treatment, residential and outpatient services for addiction and behavioral health as well as gambling counseling. Prior to that, he was chief operating officer at Coleman Professional Services, a behavioral health agency serving a five county area.

He received his bachelor’s degree from Kent State University and his master’s of business administration from The Ohio State University.

On taking over the reins at CHC, Stokes said, “It is great to be back home and I am excited about this wonderful opportunity to carry on the legacy of Ted Ziegler as we strive to get those individuals suffering from addiction into recovery.” Stokes has been working since June 1 with his predecessor, Ted Ziegler, who retired after 35 years last month.

“I am looking forward to the challenge of engaging and collaborating with the various stakeholders of CHC to further address the substance abuse and addiction needs of the greater Akron area and surrounding communities,” said Stokes. Stokes also thanked the CHC board of directors and search committee for their confidence and support.

As CEO, Stokes will be responsible for a budget of about $12 million and staff of 175. The agency served over 6,800 patients in 2012.


[Back]